26 June 2026 : Meta-Analysis
Association Between Polymorphisms of 4 Common Genes and High Myopia Risk: A Comprehensive Analysis
Qianqian Yu BC 1*, Chao Sun DE 1, Tianhua Xie FG 1, Ningzhi Wangyang DE 1, Jun Shao BE 1, Yong Yao DF 1DOI: 10.12659/MSM.952771
Med Sci Monit 2026; 32:e952771
Table 2 Characteristics of included studies about polymorphisms in 4 different genes and HM risk.
| Author | Year | Country | Ethnicity | Gene | SNP | Case | Control | SOC | |
|---|---|---|---|---|---|---|---|---|---|
| Kunceviciene et al []14 | 2018 | Lithuania | White | rs634990 | 176 | 96 | PB | ||
| Duan et al []17 | 2013 | China | Asian | rs634990 | 300 | 290 | HB | ||
| Liu et al []20 | 2021 | China | Asian | rs3743123 | 445 | 445 | PB | ||
| Liu et al []19 | 2019 | China | Asian | rs3743123 | 265 | 268 | PB | ||
| Liu et al []19 | 2019 | China | Asian | rs3743123 | 312 | 309 | PB | ||
| Mi et al []23 | 2022 | China | Asian | rs4373767 | 233 | 256 | HB | ||
| Kuang et al []18 | 2014 | China | Asian | rs4373767 | 535 | 895 | PB | ||
| Liu et al []22 | 2019 | China | Asian | rs4373767 | 605 | 211 | PB | ||
| Liu et al []24 | 2019 | China | Asian | rs4373767 | 343 | 210 | PB | ||
| Kuang et al []18 | 2014 | China | Asian | rs4428898 | 535 | 895 | PB | ||
| Liu et al []22 | 2019 | China | Asian | rs4428898 | 603 | 209 | PB | ||
| Liu et al []24 | 2019 | China | Asian | rs4428898 | 343 | 210 | PB | ||
| Kuang et al []18 | 2014 | China | Asian | rs10779363 | 525 | 905 | PB | ||
| Liu et al []22 | 2019 | China | Asian | rs10779363 | 1175 | 264 | PB | ||
| Liu et al []24 | 2019 | China | Asian | rs10779363 | 343 | 210 | PB | ||
| Kuang et al []18 | 2014 | China | Asian | rs7544369 | 532 | 906 | PB | ||
| Liu et al []22 | 2019 | China | Asian | rs7544369 | 599 | 213 | PB | ||
| Liu et al []24 | 2019 | China | Asian | rs7544369 | 343 | 210 | PB | ||
| Liu et al []21 | 2025 | China | Asian | rs1799750 | 302 | 143 | PB | ||
| Nakanishi et al []15 | 2010 | Japan | Asian | rs1799750 | 716 | 542 | PB | ||
| Liu et al. 21] | 2025 | China | Asian | rs17576 | 309 | 141 | PB | ||
| Li et al []16 | 2022 | China | Asian | rs17576 | 103 | 113 | PB | ||
| HB – hospital-based; PB – population-based; SOC – source of control; PCR – polymerase chain reaction; HWE – Hardy-Weinberg equilibrium of the control group; SNP – single-nucleotide polymorphism. | |||||||||
| Author | Case | Control | HWE | Genotype | NOS | ||||
| MM | MW | WW | MM | MW | WW | ||||
| Kunceviciene et al []14 | 28 | 105 | 43 | 41 | 42 | 13 | 0.669 | Real-Time PCR | 8 |
| Duan et al []17 | 74 | 149 | 77 | 78 | 134 | 78 | 0.196 | TaqMan SNP | 7 |
| Liu et al []20 | 15 | 131 | 299 | 16 | 170 | 259 | 0.061 | Agena MassARRAY | 8 |
| Liu et al []19 | 5 | 92 | 168 | 15 | 99 | 154 | 0.861 | Sequenom MassARRAY | 8 |
| Liu et al []19 | 13 | 91 | 208 | 7 | 117 | 185 | 0.019 | Sequenom MassARRAY | 8 |
| Mi et al []23 | 56 | 108 | 69 | 60 | 120 | 76 | 0.347 | MPCR | 7 |
| Kuang et al []18 | 56 | 212 | 267 | 100 | 370 | 425 | 0.154 | TaqMan | 7 |
| Liu et al []22 | 61 | 238 | 306 | 20 | 94 | 97 | 0.685 | TaqMan | 8 |
| Liu et al []24 | 49 | 158 | 136 | 35 | 115 | 60 | 0.094 | TaqMan | 8 |
| Kuang et al []18 | 56 | 212 | 267 | 100 | 370 | 425 | 0.154 | TaqMan | 7 |
| Liu et al []22 | 55 | 237 | 311 | 20 | 92 | 97 | 0.787 | TaqMan | 8 |
| Liu et al []24 | 48 | 163 | 132 | 37 | 116 | 57 | 0.096 | TaqMan | 8 |
| Kuang et al []18 | 55 | 205 | 265 | 96 | 375 | 434 | 0.266 | TaqMan | 7 |
| Liu et al []22 | 101 | 454 | 620 | 18 | 119 | 127 | 0.158 | TaqMan | 8 |
| Liu et al []24 | 47 | 162 | 134 | 35 | 116 | 59 | 0.083 | TaqMan | 8 |
| Kuang et al []18 | 51 | 207 | 274 | 94 | 371 | 441 | 0.226 | TaqMan | 7 |
| Liu et al []22 | 51 | 228 | 320 | 16 | 96 | 101 | 0.292 | TaqMan | 8 |
| Liu et al []24 | 40 | 170 | 133 | 35 | 115 | 60 | 0.094 | TaqMan | 8 |
| Liu et al []21 | 36 | 139 | 127 | 21 | 60 | 62 | 0.305 | MassARRAY | 8 |
| Nakanishi et al []15 | 74 | 313 | 329 | 60 | 227 | 255 | 0.378 | TaqMan | 8 |
| Liu et al. 21] | 18 | 119 | 172 | 8 | 51 | 82 | 0.984 | MassARRAY | 7 |
| Li et al []16 | 5 | 48 | 50 | 7 | 54 | 52 | 0.148 | Sequenom MassARRAY | 7 |
| HB – hospital-based; PB – population-based; SOC – source of control; PCR – polymerase chain reaction; HWE – Hardy-Weinberg equilibrium of the control group; SNP – single-nucleotide polymorphism. | |||||||||






